1360 related articles for article (PubMed ID: 31801180)
21. Update on Vaccine-Derived Polioviruses - Worldwide, January 2014-March 2015.
Diop OM; Burns CC; Sutter RW; Wassilak SG; Kew OM;
MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(23):640-6. PubMed ID: 26086635
[TBL] [Abstract][Full Text] [Related]
22. Immunogenicity and safety evaluation of bivalent types 1 and 3 oral poliovirus vaccine by comparing different poliomyelitis vaccination schedules in China: A randomized controlled non-inferiority clinical trial.
Qiu J; Yang Y; Huang L; Wang L; Jiang Z; Gong J; Wang W; Wang H; Guo S; Li C; Wei S; Mo Z; Xia J
Hum Vaccin Immunother; 2017 Jun; 13(6):1-10. PubMed ID: 28362135
[TBL] [Abstract][Full Text] [Related]
23. Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP).
Prevots DR; Burr RK; Sutter RW; Murphy TV;
MMWR Recomm Rep; 2000 May; 49(RR-5):1-22; quiz CE1-7. PubMed ID: 15580728
[TBL] [Abstract][Full Text] [Related]
24. Impact of Maternal Antibody on the Immunogenicity of Inactivated Polio Vaccine in Infants Immunized With Bivalent Oral Polio Vaccine: Implications for the Polio Eradication Endgame.
Gaensbauer JT; Gast C; Bandyopadhyay AS; O'Ryan M; Saez-Llorens X; Rivera L; Lopez-Medina E; Melgar M; Weldon WC; Oberste MS; Rüttimann R; Clemens R; Asturias EJ
Clin Infect Dis; 2018 Oct; 67(suppl_1):S57-S65. PubMed ID: 30376095
[TBL] [Abstract][Full Text] [Related]
25. Introduction of Inactivated Poliovirus Vaccine and Impact on Vaccine-Associated Paralytic Poliomyelitis - Beijing, China, 2014-2016.
Zhao D; Ma R; Zhou T; Yang F; Wu J; Sun H; Liu F; Lu L; Li X; Zuo S; Yao W; Yin J
MMWR Morb Mortal Wkly Rep; 2017 Dec; 66(49):1357-1361. PubMed ID: 29240729
[TBL] [Abstract][Full Text] [Related]
26. Pediatric HIV Infection and Decreased Prevalence of OPV Point Mutations Linked to Vaccine-associated Paralytic Poliomyelitis.
Halpern MS; Altamirano J; Maldonado Y
Clin Infect Dis; 2018 Oct; 67(suppl_1):S78-S84. PubMed ID: 30376083
[TBL] [Abstract][Full Text] [Related]
27. Intestinal Immunity to Poliovirus Following Sequential Trivalent Inactivated Polio Vaccine/Bivalent Oral Polio Vaccine and Trivalent Inactivated Polio Vaccine-only Immunization Schedules: Analysis of an Open-label, Randomized, Controlled Trial in Chilean Infants.
Brickley EB; Wieland-Alter W; Connor RI; Ackerman ME; Boesch AW; Arita M; Weldon WC; O'Ryan MG; Bandyopadhyay AS; Wright PF
Clin Infect Dis; 2018 Oct; 67(suppl_1):S42-S50. PubMed ID: 30376086
[TBL] [Abstract][Full Text] [Related]
28. Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infants.
Wright PF; Connor RI; Wieland-Alter WF; Hoen AG; Boesch AW; Ackerman ME; Oberste MS; Gast C; Brickley EB; Asturias EJ; Rüttimann R; Bandyopadhyay AS
Lancet Infect Dis; 2016 Dec; 16(12):1377-1384. PubMed ID: 27638357
[TBL] [Abstract][Full Text] [Related]
29. Exploring the relationship between polio type 2 serum neutralizing antibodies and intestinal immunity using data from two randomized controlled trials of new bOPV-IPV immunization schedules.
Bandyopadhyay AS; Asturias EJ; O'Ryan M; Oberste MS; Weldon W; Clemens R; Rüttimann R; Modlin JF; Gast C
Vaccine; 2017 Dec; 35(52):7283-7291. PubMed ID: 29150209
[TBL] [Abstract][Full Text] [Related]
30. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
Orenstein WA;
Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328
[TBL] [Abstract][Full Text] [Related]
31. Inactivated polio vaccines from three different manufacturers have equivalent safety and immunogenicity when given as 1 or 2 additional doses after bivalent OPV: Results from a randomized controlled trial in Latin America.
Lopez-Medina E; Melgar M; Gaensbauer JT; Bandyopadhyay AS; Borate BR; Weldon WC; Rüttimann R; Ward J; Clemens R; Asturias EJ
Vaccine; 2017 Jun; 35(28):3591-3597. PubMed ID: 28455172
[TBL] [Abstract][Full Text] [Related]
32. Guidance for Assessment of Poliovirus Vaccination Status and Vaccination of Children Who Have Received Poliovirus Vaccine Outside the United States.
Marin M; Patel M; Oberste S; Pallansch MA
MMWR Morb Mortal Wkly Rep; 2017 Jan; 66(1):23-25. PubMed ID: 28081056
[TBL] [Abstract][Full Text] [Related]
33. The challenge of changing the inactivated poliomyelitis vaccine in Latin America: declaration of the Latin American Society of Pediatric Infectious Diseases (SLIPE).
Falleiros-Arlant LH; Avila-Agüero ML; Brea del Castillo J; Mariño C
Rev Chilena Infectol; 2014 Oct; 31(5):590-603. PubMed ID: 25491459
[TBL] [Abstract][Full Text] [Related]
34. Budget impact of polio immunization strategy for India: introduction of one dose of inactivated poliomyelitis vaccine and reductions in supplemental polio immunization.
Khan MM; Sharma S; Tripathi B; Alvarez FP
Public Health; 2017 Jan; 142():31-38. PubMed ID: 28057194
[TBL] [Abstract][Full Text] [Related]
35. Reduced mucosal immunity to poliovirus after cessation of trivalent oral polio vaccine.
Zhao T; Li J; Shi H; Ye H; Ma R; Fu Y; Liu X; Li G; Yang X; Zhao Z; Yang J
Hum Vaccin Immunother; 2021 Aug; 17(8):2560-2567. PubMed ID: 33848232
[TBL] [Abstract][Full Text] [Related]
36. Immunogenicity of Two Different Sequential Schedules of Inactivated Polio Vaccine Followed by Oral Polio Vaccine Versus Oral Polio Vaccine Alone in Healthy Infants in China.
Li RC; Li CG; Wang HB; Luo HM; Li YP; Wang JF; Ying ZF; Yu WZ; Shu JD; Wen N; Vidor E
J Pediatric Infect Dis Soc; 2016 Sep; 5(3):287-96. PubMed ID: 26407255
[TBL] [Abstract][Full Text] [Related]
37. Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial.
John J; Giri S; Karthikeyan AS; Iturriza-Gomara M; Muliyil J; Abraham A; Grassly NC; Kang G
Lancet; 2014 Oct; 384(9953):1505-12. PubMed ID: 25018120
[TBL] [Abstract][Full Text] [Related]
38. Vaccine policy changes and epidemiology of poliomyelitis in the United States.
Alexander LN; Seward JF; Santibanez TA; Pallansch MA; Kew OM; Prevots DR; Strebel PM; Cono J; Wharton M; Orenstein WA; Sutter RW
JAMA; 2004 Oct; 292(14):1696-701. PubMed ID: 15479934
[TBL] [Abstract][Full Text] [Related]
39. The cost-effectiveness of alternative polio immunization policies in South Africa.
Griffiths UK; Botham L; Schoub BD
Vaccine; 2006 Jul; 24(29-30):5670-8. PubMed ID: 16766096
[TBL] [Abstract][Full Text] [Related]
40. Vaccine-associated paralytic poliomyelitis in the Russian Federation in 1998-2014.
Ivanova OE; Eremeeva TP; Morozova NS; Shakaryan AK; Korotkova EA; Kozlovskaya LI; Baykova OY; Krasota AY; Gmyl AP
Int J Infect Dis; 2018 Nov; 76():64-69. PubMed ID: 30201507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
